Effect of Somatosensory Interaction Transcutaneous Electrical Acupoint Stimulation on Cancer-related Fatigue and Immunity: A Randomized Controlled Trial.

Authors:
Shu J; Ren W; Chen S; Li L; Zhu H and 1 more

Journal:
Am J Clin Oncol

Publication Year: 2022

DOI:
10.1097/COC.0000000000000922

PMCID:
PMC9213073

PMID:
35616251

Journal Information

Full Title: Am J Clin Oncol

Abbreviation: Am J Clin Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare no conflicts of interest."

Evidence found in paper:

"This research was supported by Zhejiang Provincial Basic Public Welfare Research Project under Grant No. LGF20H290002 and Traditional Chinese Medicine Scientific Research Fund Project of Zhejiang Province under Grant No. 2022ZB016."

Evidence found in paper:

"This study was a randomized controlled trial design. The study protocol had been registered in China Clinical Trial Registration Center with registration number: ChiCTR2100045655. The study had been approved by the Ethics Committee of Zhejiang Provincial People’s Hospital (approval number: 2021QT133). Written informed consents had been obtained from all the participants. Methods:: The study protocol had been registered in China Clinical Trial Registration Center with registration number: ChiCTR2100045655. CRF patients were equally divided into SI-TEAS Group, Acupressure Group and Sham Acupressure Group to receive SI-TEAS, acupressure and sham acupressure treatments 5 times a week. The fatigue levels of patients in the 3 groups were measured by the Piper Fatigue Scale during the baseline period and after 4 and 8 weeks (of treatment). The cell immunity of these patients was determined by detecting the T-lymphocyte subsets and NK cells."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025